Skip to main content

Table 2 Clinical response after SOX neoadjuvant chemotherapy

From: Surgical outcomes in patients with locally advanced gastric cancer treated with S-1 and oxaliplatin as neoadjuvant chemotherapy

Response

No. of patients

% (95% CI)

CR

10

12.5

PR

45

56.3

SD

23

28.7

PD

2

2.5

Overall response rate

55

68.8 (58.6–79.0)

Disease control rate

78

97.5 (94.1–100)

  1. CI confidence interval, CR complete response, PR partial response, SD stable disease, PD progressive disease. Disease control rate = CR + PR + SD.